Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06996704
What this trial is testing

A Clinical Study of AK0610

Who this might be right for
Healthy Volunteer Study
Shanghai Ark Biopharmaceutical Co., Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT00534352
What this trial is testing

Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Who this might be right for
HIV-1 Infection
Tibotec, Inc 23
Early research (Phase 1)Ended earlyNCT01278758
What this trial is testing

A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function

Who this might be right for
Metastatic Cancer
Novartis Pharmaceuticals 7
Early research (Phase 1)Study completedNCT03269136
What this trial is testing

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 101
Early research (Phase 1)Study completedNCT01227252
What this trial is testing

A Safety Study of LY2886721 Multiple Doses in Healthy Subjects

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 42
Testing effectiveness (Phase 2)Looking for participantsNCT07478744
What this trial is testing

A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder
Synendos Therapeutics AG 24
Early research (Phase 1)Study completedNCT06049147
What this trial is testing

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Who this might be right for
Safety and Pharmacokinetic
Medibiofarma S.L. 72
Early research (Phase 1)Study completedNCT00787007
What this trial is testing

Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers

Who this might be right for
Healthy
Ausio Pharmaceuticals, LLC 60
Large-scale testing (Phase 3)Study completedNCT01515007
What this trial is testing

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

Who this might be right for
Non Cystic Fibrosis Bronchiectasis
Aradigm Corporation 278
Early research (Phase 1)Study completedNCT06281132
What this trial is testing

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

Who this might be right for
Hypertension
Chong Kun Dang Pharmaceutical 51
Early research (Phase 1)Study completedNCT01596400
What this trial is testing

Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Kyowa Kirin Pharmaceutical Development Ltd 19
Testing effectiveness (Phase 2)WithdrawnNCT03649464
What this trial is testing

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Who this might be right for
GlioblastomaAstrocytomaOligodendroglioma
Oblato, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07644832
What this trial is testing

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Who this might be right for
Hemophilia AHemophilia BFactor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd. 76
Testing effectiveness (Phase 2)Study completedNCT01746771
What this trial is testing

A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer

Who this might be right for
HER-2 Positive Advanced Gastric Cancer
Hanmi Pharmaceutical Company Limited 44
Early research (Phase 1)Study completedNCT00984971
What this trial is testing

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

Who this might be right for
HIV PreventionHIV Infections
CONRAD 18
Early research (Phase 1)Study completedNCT02111330
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF -509 (80 mg, 160 mg and 240 mg) "After Multiple Oral Doses" in Healthy Volunteers

Who this might be right for
Parkinson Disease
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 16
Early research (Phase 1)Study completedNCT06889064
What this trial is testing

Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 28
Early research (Phase 1)Study completedNCT07149220
What this trial is testing

Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults With Premalignant Oral Lesions.

Who this might be right for
Oral LeukoplakiaOral Dysplasia
Ohio State University Comprehensive Cancer Center 7
Early research (Phase 1)Study completedNCT03169959
What this trial is testing

Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 85
Early research (Phase 1)Study completedNCT05351840
What this trial is testing

To Evaluate the Pharmacokinetic Interactions and Safety in Healthy Volunteers

Who this might be right for
Healthy
JW Pharmaceutical 31
Next Page